198 related articles for article (PubMed ID: 32383794)
1. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
Haeberle B; Rangaswami A; Krailo M; Czauderna P; Hiyama E; Maibach R; Lopez-Terrada D; Aronson DC; Alaggio R; Ansari M; Malogolowkin MH; Perilongo G; O'Neill AF; Trobaugh-Lotrario AD; Watanabe K; Schmid I; von Schweinitz D; Ranganathan S; Yoshimura K; Hishiki T; Tanaka Y; Piao J; Feng Y; Rinaldi E; Saraceno D; Derosa M; Meyers RL
Pediatr Blood Cancer; 2020 Aug; 67(8):e28350. PubMed ID: 32383794
[TBL] [Abstract][Full Text] [Related]
2. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
[TBL] [Abstract][Full Text] [Related]
3. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
5. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
6. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
7. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
[TBL] [Abstract][Full Text] [Related]
8. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatoblastoma in the United States: Can we do better?
Ziogas IA; Benedetti DJ; Wu WK; Matsuoka LK; Izzy M; Rauf MA; Pai AK; Bailey CE; Alexopoulos SP
Surgery; 2021 Aug; 170(2):579-586. PubMed ID: 33526266
[TBL] [Abstract][Full Text] [Related]
11. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
12. A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma.
Kondo T; Honda S; Suzuki H; Ito YM; Kawakita I; Okumura K; Ara M; Minato M; Kitagawa N; Tanaka Y; Tanaka M; Shinkai M; Hishiki T; Watanabe K; Ida K; Takatori A; Hiyama E; Taketomi A
Eur J Cancer; 2022 Sep; 172():311-322. PubMed ID: 35816972
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.
Wang TY; Han YL; Gao YJ; Xu M; Gu S; Yin MZ; Zhong YM; Hu WT; Pan C; Tang JY
Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):471-478. PubMed ID: 31000431
[TBL] [Abstract][Full Text] [Related]
14. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
15. [A follow-up report of childhood hepatoblastoma from 74 cases in a single center].
Wang TY; Pan C; Tang JY; Ye QD; Zhou M; Gao YJ; Hu WT
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):364-368. PubMed ID: 28482388
[No Abstract] [Full Text] [Related]
16. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan.
Hsu WY; Chang HH; Lu MY; Yang YL; Jou ST; Chen HL; Ni YH; Hsu HY; Chang MH; Wu JF
Pediatr Neonatol; 2020 Aug; 61(4):393-398. PubMed ID: 32291200
[TBL] [Abstract][Full Text] [Related]
17. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
[TBL] [Abstract][Full Text] [Related]
18. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
19. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update.
Ranganathan S; Lopez-Terrada D; Alaggio R
Pediatr Dev Pathol; 2020; 23(2):79-95. PubMed ID: 31554479
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.
Trobaugh-Lotrario AD; Katzenstein HM
Pediatr Blood Cancer; 2012 Nov; 59(5):809-12. PubMed ID: 22648979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
